These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 8567880)

  • 41. Evaluation of virulence factors of Candida albicans isolated from HIV-positive individuals using HAART.
    de Paula Menezes R; de Melo Riceto ÉB; Borges AS; de Brito Röder DV; dos Santos Pedroso R
    Arch Oral Biol; 2016 Jun; 66():61-5. PubMed ID: 26913969
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters.
    Sanglard D; Kuchler K; Ischer F; Pagani JL; Monod M; Bille J
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2378-86. PubMed ID: 8585712
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oropharyngeal candidiasis in HIV-infected patients under treatment with protease inhibitors.
    Migliorati CA; Birman EG; Cury AE
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 Sep; 98(3):301-10. PubMed ID: 15356467
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Low levels of antigenic variability in fluconazole-susceptible and -resistant Candida albicans isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis.
    Lopez-Ribot JL; McAtee RK; Kirkpatrick WR; La Valle R; Patterson TF
    Clin Diagn Lab Immunol; 1999 Sep; 6(5):665-70. PubMed ID: 10473514
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinically significant azole cross-resistance in Candida isolates from HIV-positive patients with oral candidosis.
    Cartledge JD; Midgley J; Gazzard BG
    AIDS; 1997 Dec; 11(15):1839-44. PubMed ID: 9412702
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cross-sectional study of the susceptibility of Candida isolates to antifungal drugs and in vitro-in vivo correlation in HIV-infected patients.
    Chavanet P; Lopez J; Grappin M; Bonnin A; Duong M; Waldner A; Buisson M; Camerlynck P; Portier H
    AIDS; 1994 Jul; 8(7):945-50. PubMed ID: 7946104
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Elevated aspartic proteinase secretion and experimental pathogenicity of Candida albicans isolates from oral cavities of subjects infected with human immunodeficiency virus.
    De Bernardis F; Chiani P; Ciccozzi M; Pellegrini G; Ceddia T; D'Offizzi G; Quinti I; Sullivan PA; Cassone A
    Infect Immun; 1996 Feb; 64(2):466-71. PubMed ID: 8550193
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Emergence of fluconazole-resistant strains of Candida albicans in patients with recurrent oropharyngeal candidosis and human immunodeficiency virus infection.
    Ruhnke M; Eigler A; Tennagen I; Geiseler B; Engelmann E; Trautmann M
    J Clin Microbiol; 1994 Sep; 32(9):2092-8. PubMed ID: 7814530
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vivo virulence of Candida albicans isolates causing mucosal infections in people infected with the human immunodeficiency virus.
    Taylor BN; Fichtenbaum C; Saavedra M; Slavinsky III J; Swoboda R; Wozniak K; Arribas A; Powderly W; Fidel PL
    J Infect Dis; 2000 Sep; 182(3):955-9. PubMed ID: 10950797
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Emergence of resistance of Candida albicans to clotrimazole in human immunodeficiency virus-infected children: in vitro and clinical correlations.
    Pelletier R; Peter J; Antin C; Gonzalez C; Wood L; Walsh TJ
    J Clin Microbiol; 2000 Apr; 38(4):1563-8. PubMed ID: 10747144
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterization of genetically distinct subgroup of Candida albicans strains isolated from oral cavities of patients infected with human immunodeficiency virus.
    McCullough M; Ross B; Reade P
    J Clin Microbiol; 1995 Mar; 33(3):696-700. PubMed ID: 7751379
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of virulence factors and antifungal susceptibility patterns of different Candida species isolated from the female camel (Camelus dromedarius) genital tract.
    Sharifzadeh A; Soltani M; Shokri H
    Mycoses; 2015 Aug; 58(8):478-84. PubMed ID: 26152466
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Oral Candida albicans from patients infected with the human immunodeficiency virus and characterization of a genetically distinct subgroup of Candida albicans.
    McCullough M; Ross B; Reade PC
    Aust Dent J; 1995 Apr; 40(2):91-7. PubMed ID: 7786236
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of the E test for fluconazole susceptibility testing of Candida albicans isolates from oropharyngeal candidiasis.
    Dannaoui E; Colin S; Pichot J; Piens MA
    Eur J Clin Microbiol Infect Dis; 1997 Mar; 16(3):228-32. PubMed ID: 9131326
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of the human immunodeficiency virus (HIV) proteinase inhibitors saquinavir and indinavir on in vitro activities of secreted aspartyl proteinases of Candida albicans isolates from HIV-infected patients.
    Korting HC; Schaller M; Eder G; Hamm G; Böhmer U; Hube B
    Antimicrob Agents Chemother; 1999 Aug; 43(8):2038-42. PubMed ID: 10428932
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Difference in virulence between fluconazole-susceptible and fluconazole-resistant Candida albicans in a mouse model.
    Schulz B; Weber K; Schmidt A; Borg-von Zepelin M; Ruhnke M
    Mycoses; 2011 Sep; 54(5):e522-30. PubMed ID: 21605180
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fluconazole susceptibility and strain variation of Candida albicans isolates from HIV-infected patients with oropharyngeal candidosis.
    Barchiesi F; Arzeni D; Del Prete MS; Sinicco A; Falconi Di Francesco L; Pasticci MB; Lamura L; Nuzzo MM; Burzacchini F; Coppola S; Chiodo F; Scalise G
    J Antimicrob Chemother; 1998 May; 41(5):541-8. PubMed ID: 9630407
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Azole cross-resistance to ketoconazole, fluconazole, itraconazole and voriconazole in clinical Candida albicans isolates from HIV-infected children with oropharyngeal candidosis.
    Müller FM; Weig M; Peter J; Walsh TJ
    J Antimicrob Chemother; 2000 Aug; 46(2):338-40. PubMed ID: 10933673
    [No Abstract]   [Full Text] [Related]  

  • 59. Declining rates of oropharyngeal candidiasis and carriage of Candida albicans associated with trends toward reduced rates of carriage of fluconazole-resistant C. albicans in human immunodeficiency virus-infected patients.
    Martins MD; Lozano-Chiu M; Rex JH
    Clin Infect Dis; 1998 Nov; 27(5):1291-4. PubMed ID: 9827284
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Increased serum and salivary immunoglobulins against Candida albicans in HIV-infected patients with oral candidiasis.
    Drobacheff C; Millon L; Monod M; Piarroux R; Robinet E; Laurent R; Meillet D
    Clin Chem Lab Med; 2001 Jun; 39(6):519-26. PubMed ID: 11506465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.